Haleon: Perbedaan antara revisi

'''Haleon plc''' adalah perusahaan kesehatan konsumen multinasional Inggris dengan kantor pusat di [[Jembatan jembatan|Weybridge]], [[Inggris]].<ref>{{Cite web|title=GSK announces independent Consumer Healthcare company is to be called Haleon {{!}} GSK|url=https://www.gsk.com/en-gb/media/press-releases/gsk-announces-independent-consumer-healthcare-company-is-to-be-called-haleon/|website=www.gsk.com|language=en-GB|access-date=2023-02-21}}</ref> Perusahaan ini adalah salah satu bisnis perawatan kesehatan konsumen terbesar di dunia, dengan merek termasuk [[pasta gigi]] [[Sensodyne]], [[Analgesik|obat penghilang rasa sakit]] [[Parasetamol|Panadol]] dan [[Ibuprofen|Advil]] serta [[vitamin]] [[Centrum (multivitamin)|Centrum]].<ref>{{Cite news|last=Ralph|first=Alex|date=2 July 2022|title=GlaxoSmithKline prepares to get back to basics with historic break-up|url=https://www.thetimes.co.uk/article/three-centuries-of-gsk-story-about-to-add-a-new-chapter-3jrbn8kkq|work=[[The Times]]|access-date=4 July 2022}}</ref> Perusahaan ini adalah pemimpin global dalam obat [[Penggolongan Obat|bebas]] dengan pangsa pasar 7,3 persen.<ref name="forbes1">{{Cite news|last=Cornell|first=Joe|date=15 July 2021|title=GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022|url=https://www.forbes.com/sites/joecornell/2021/07/15/glaxosmithkline-to-spin-off-consumer-healthcare-business-by-mid-2022/?sh=723ac83372d0|work=[[Forbes]]|access-date=10 June 2022}}</ref>

 

 

Sir [[Dave Lewis (pengusaha)|David Lewis]] adalah [[ketua]], dengan Brian McNamara sebagai CEO.<ref name="haleonsky">{{Cite news|last=Kleinman|first=Mark|date=3 May 2022|title=GSK's £45bn Panadol and Sensodyne-maker Haleon in talks to hire banks|url=https://news.sky.com/story/gsks-45bn-panadol-and-sensodyne-maker-haleon-in-talks-to-hire-banks-12604875|work=[[Sky News]]|access-date=10 June 2022}}</ref> Haleon terdaftar di [[Bursa Efek London|London Stock Exchange]] dan merupakan komponen dari [[Indeks FTSE 100|FTSE 100]], dengan listing sekunder di [[Bursa Efek New York|New York Stock Exchange]] . Penjualan tahunan berjumlah sekitar £10 miliar di 120 pasar pada tahun 2020.<ref name="forbes12">{{Cite news|last=Cornell|first=Joe|date=15 July 2021|title=GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022|url=https://www.forbes.com/sites/joecornell/2021/07/15/glaxosmithkline-to-spin-off-consumer-healthcare-business-by-mid-2022/?sh=723ac83372d0|work=[[Forbes]]|access-date=10 June 2022}}</ref>